Clinical trial · Observational
Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization
NCT03486262CI-TRIAL-00035230K-FPIunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the records of the pulmonology and pathology departments of our various partners.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer and Idiopathic Pulmonary Fibrosis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Lung carcinoma on IPF
- description
- Lung carcinoma on IPF
Primary outcomes (1)
- measure
- Molecular profile of IPF-associated lung carcinomas
- timeFrame
- 1 month / 8 samples
- description
- Next generation sequencing of carcinomas with Ion S5 XL sequencer and Oncomine™ Comprehensive Panel
Secondary outcomes (1)
- measure
- Pathological characterization of lung carcinomas
- timeFrame
- 1 month / 8 samples
- description
- Histological classification of carcinomas and immunohistochemistry with lineage markers
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Lung carcinoma * Idiopathic pulmonary fibrosis Exclusion Criteria: \- No tumor sample available
References
Publications (0)
Data not yet available
No reference posted for this study.